Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence
Abstract Prenatal sonographic diagnosis of congenital heart disease (CHD) can lead to improved morbidity and mortality. However, the diagnostic accuracy of ultrasound, the sole prenatal screening tool, remains limited. Failed prenatal or early newborn detection of cyanotic CHD (CCHD) can have disast...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-025-85216-7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832594676103774208 |
---|---|
author | Ray Bahado-Singh Nadia Ashrafi Amin Ibrahim Buket Aydas Ali Yilmaz Perry Friedman Stewart F. Graham Onur Turkoglu |
author_facet | Ray Bahado-Singh Nadia Ashrafi Amin Ibrahim Buket Aydas Ali Yilmaz Perry Friedman Stewart F. Graham Onur Turkoglu |
author_sort | Ray Bahado-Singh |
collection | DOAJ |
description | Abstract Prenatal sonographic diagnosis of congenital heart disease (CHD) can lead to improved morbidity and mortality. However, the diagnostic accuracy of ultrasound, the sole prenatal screening tool, remains limited. Failed prenatal or early newborn detection of cyanotic CHD (CCHD) can have disastrous consequences. We therefore sought to use a Precision Fetal Cardiology based approach combining metabolomic profiling of maternal saliva and machine learning, a major branch of artificial intelligence (AI), for the prenatal detection of isolated, non-syndromic cyanotic CHD. Metabolomic analyses using Ultra-High Performance Liquid Chromatography/Mass Spectrometry identified 468 metabolites in the saliva. Six different AI platforms were utilized for the detection of CCHD and CHD overall. AI achieved excellent accuracy for the CCHD detection: Area Under the ROC curve: AUC (95% CI) = 0.819 (0.635-1.00) with a sensitivity and specificity of 92.5% and 87.0%, and for CHD overall: AUC (95% CI) = 0.828 (0.635-1.00) with a sensitivity of 90.5% and specificity of 88.0%. Similarly high accuracies were achieved for the detection of CHD overall: AUC (95% CI) = 0.8488 (0.635-1.00) with a sensitivity of 92.5% and specificity of 91.0%. Pathway analysis showed significant alterations in Arachidonic Acid, Alpha-linoleic acid, and Tryptophan metabolism indicating significant lipid dysfunction in cyanotic CHD. In summary, we report for the first time, the accurate detection of non-syndromic cyanotic CHD using maternal salivary metabolomics. Further, analysis revealed significant alteration of lipid metabolism. |
format | Article |
id | doaj-art-26e4a578ebb9411ea42261f5ed8ab2fb |
institution | Kabale University |
issn | 2045-2322 |
language | English |
publishDate | 2025-01-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj-art-26e4a578ebb9411ea42261f5ed8ab2fb2025-01-19T12:23:38ZengNature PortfolioScientific Reports2045-23222025-01-0115111110.1038/s41598-025-85216-7Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligenceRay Bahado-Singh0Nadia Ashrafi1Amin Ibrahim2Buket Aydas3Ali Yilmaz4Perry Friedman5Stewart F. Graham6Onur Turkoglu7Department of Obstetrics and Gynecology, Corewell Health William Beaumont University Hospital, Oakland University William Beaumont School of MedicineMetabolomics Department, Corewell Health William Beaumont University Hospital, Beaumont Research InstituteMetabolomics Department, Corewell Health William Beaumont University Hospital, Beaumont Research InstituteDepartment of Care Management Analytics, Blue Cross Blue Shield of MichiganMetabolomics Department, Corewell Health William Beaumont University Hospital, Beaumont Research InstituteDepartment of Obstetrics and Gynecology, Corewell Health William Beaumont University Hospital, Oakland University William Beaumont School of MedicineDepartment of Obstetrics and Gynecology, Corewell Health William Beaumont University Hospital, Oakland University William Beaumont School of MedicineDepartment of Obstetrics and Gynecology, Baylor College of Medicine, Texas Children’s HospitalAbstract Prenatal sonographic diagnosis of congenital heart disease (CHD) can lead to improved morbidity and mortality. However, the diagnostic accuracy of ultrasound, the sole prenatal screening tool, remains limited. Failed prenatal or early newborn detection of cyanotic CHD (CCHD) can have disastrous consequences. We therefore sought to use a Precision Fetal Cardiology based approach combining metabolomic profiling of maternal saliva and machine learning, a major branch of artificial intelligence (AI), for the prenatal detection of isolated, non-syndromic cyanotic CHD. Metabolomic analyses using Ultra-High Performance Liquid Chromatography/Mass Spectrometry identified 468 metabolites in the saliva. Six different AI platforms were utilized for the detection of CCHD and CHD overall. AI achieved excellent accuracy for the CCHD detection: Area Under the ROC curve: AUC (95% CI) = 0.819 (0.635-1.00) with a sensitivity and specificity of 92.5% and 87.0%, and for CHD overall: AUC (95% CI) = 0.828 (0.635-1.00) with a sensitivity of 90.5% and specificity of 88.0%. Similarly high accuracies were achieved for the detection of CHD overall: AUC (95% CI) = 0.8488 (0.635-1.00) with a sensitivity of 92.5% and specificity of 91.0%. Pathway analysis showed significant alterations in Arachidonic Acid, Alpha-linoleic acid, and Tryptophan metabolism indicating significant lipid dysfunction in cyanotic CHD. In summary, we report for the first time, the accurate detection of non-syndromic cyanotic CHD using maternal salivary metabolomics. Further, analysis revealed significant alteration of lipid metabolism.https://doi.org/10.1038/s41598-025-85216-7 |
spellingShingle | Ray Bahado-Singh Nadia Ashrafi Amin Ibrahim Buket Aydas Ali Yilmaz Perry Friedman Stewart F. Graham Onur Turkoglu Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence Scientific Reports |
title | Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence |
title_full | Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence |
title_fullStr | Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence |
title_full_unstemmed | Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence |
title_short | Precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence |
title_sort | precision fetal cardiology detects cyanotic congenital heart disease using maternal saliva metabolome and artificial intelligence |
url | https://doi.org/10.1038/s41598-025-85216-7 |
work_keys_str_mv | AT raybahadosingh precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence AT nadiaashrafi precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence AT aminibrahim precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence AT buketaydas precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence AT aliyilmaz precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence AT perryfriedman precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence AT stewartfgraham precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence AT onurturkoglu precisionfetalcardiologydetectscyanoticcongenitalheartdiseaseusingmaternalsalivametabolomeandartificialintelligence |